A Randomized Trial on Resveratrol Supplement Affecting Lipid Profile and Other Metabolic Markers in Subjects with Dyslipidemia

Resveratrol is a polyphenol with a well-established beneficial effect on dyslipidemia and hyperuricemia in preclinical experiments. Nonetheless, its efficacy and dose–response relationship in clinical trials remains unclear. This study examined whether resveratrol supplement improves the serum lipid...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yuqing, Zeng, Yupeng, Pan, Zhijun, Jin, Yufeng, Li, Qing, Pang, Juan, Wang, Xin, Chen, Yu, Yang, Yan, Ling, Wenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921501/
https://www.ncbi.nlm.nih.gov/pubmed/36771199
http://dx.doi.org/10.3390/nu15030492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921501/
https://www.ncbi.nlm.nih.gov/pubmed/36771199
http://dx.doi.org/10.3390/nu15030492

Ejemplares similares